<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01343316</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00041559</org_study_id>
    <nct_id>NCT01343316</nct_id>
  </id_info>
  <brief_title>Benefits of Post-Pyloric Feeding Tubes in Critically Ill Patients</brief_title>
  <official_title>Benefits of Post-Pyloric Feeding Tubes in Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the benefit of feeding critically-ill patients
      beyond the stomach (post-pyloric). Furthermore, because of the advent of two new post-pyloric
      feeding tubes (Tiger 2 and Syncro BlueTube) designed to improve post-pyloric placement, the
      investigators will be evaluating the benefits of those two tubes as well.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    lack of funding
  </why_stopped>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To determine whether transpyloric feeds are superior to transgastric feeds with regard to ability to give calories and meet nutritional goals.</measure>
    <time_frame>one year</time_frame>
    <description>To determine the time to goal calories. To determine the number and qualitative aspect of tracheal aspirations. To determine the time to initiate tube feeds once the decision has been made to place a tube, the number of x-rays required for placement, the time required for placement, the number of times tube needs to be replaced.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine the benefits of utilizing one type of transpyloric tube over another. One placed in the transpyloric position magnetically; the other propelled by peristalsis itself.</measure>
    <time_frame>one year</time_frame>
    <description>Benefits include shorter time to appropriate placement and quicker time to goal tube feed rate.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">21</enrollment>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Transgastric tube</arm_group_label>
    <description>Nasogastric (NG tube)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transpyloric tube - Tiger2</arm_group_label>
    <description>Self-propelled by paristaltic waves of the stomach</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transpyloric tube - Syncro BlueTube</arm_group_label>
    <description>Magnetically placed</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transpyloric feeding tubes (Nasogastric Tube (NG tube), Tiger2, Syncro BlueTube)</intervention_name>
    <description>To determine the benefits of utilizing one type of transpyloric tube over another.</description>
    <arm_group_label>Transgastric tube</arm_group_label>
    <arm_group_label>Transpyloric tube - Tiger2</arm_group_label>
    <arm_group_label>Transpyloric tube - Syncro BlueTube</arm_group_label>
    <other_name>Nasogastric Tube (NG tube)</other_name>
    <other_name>Tiger2</other_name>
    <other_name>Syncro BlueTube</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Critically ill patients in the ICU setting
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients admitted to the ICU who are deemed by the attending critical care physician
             to warrant tube feeds and expected to receive tube feeds for more than three days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glenn Whitman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Montejo JC, Miñambres E, Bordejé L, Mesejo A, Acosta J, Heras A, Ferré M, Fernandez-Ortega F, Vaquerizo CI, Manzanedo R. Gastric residual volume during enteral nutrition in ICU patients: the REGANE study. Intensive Care Med. 2010 Aug;36(8):1386-93. doi: 10.1007/s00134-010-1856-y. Epub 2010 Mar 16.</citation>
    <PMID>20232036</PMID>
  </reference>
  <reference>
    <citation>Hsu CW, Sun SF, Lin SL, Kang SP, Chu KA, Lin CH, Huang HH. Duodenal versus gastric feeding in medical intensive care unit patients: a prospective, randomized, clinical study. Crit Care Med. 2009 Jun;37(6):1866-72. doi: 10.1097/CCM.0b013e31819ffcda.</citation>
    <PMID>19384225</PMID>
  </reference>
  <reference>
    <citation>Acosta-Escribano J, Fernández-Vivas M, Grau Carmona T, Caturla-Such J, Garcia-Martinez M, Menendez-Mainer A, Solera-Suarez M, Sanchez-Payá J. Gastric versus transpyloric feeding in severe traumatic brain injury: a prospective, randomized trial. Intensive Care Med. 2010 Sep;36(9):1532-9. doi: 10.1007/s00134-010-1908-3. Epub 2010 May 22.</citation>
    <PMID>20495781</PMID>
  </reference>
  <reference>
    <citation>Heyland DK, Drover JW, MacDonald S, Novak F, Lam M. Effect of postpyloric feeding on gastroesophageal regurgitation and pulmonary microaspiration: results of a randomized controlled trial. Crit Care Med. 2001 Aug;29(8):1495-501.</citation>
    <PMID>11505114</PMID>
  </reference>
  <reference>
    <citation>Davies AR, Froomes PR, French CJ, Bellomo R, Gutteridge GA, Nyulasi I, Walker R, Sewell RB. Randomized comparison of nasojejunal and nasogastric feeding in critically ill patients. Crit Care Med. 2002 Mar;30(3):586-90.</citation>
    <PMID>11990920</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2011</study_first_submitted>
  <study_first_submitted_qc>April 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2011</study_first_posted>
  <last_update_submitted>September 17, 2013</last_update_submitted>
  <last_update_submitted_qc>September 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Glenn Whitman</investigator_full_name>
    <investigator_title>Associate Professor, Director of CVSICU and Adult Heart Transplant</investigator_title>
  </responsible_party>
  <keyword>Enteral Feeds</keyword>
  <keyword>Supplemental Feeds</keyword>
  <keyword>Transpyloric Tube</keyword>
  <keyword>Nasogastric Tube</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

